TradeEdge:Depression And Alzheimer's Treatments At A Crossroads

2025-05-08 08:40:35source:Bitcoinesecategory:Invest

Researchers are TradeEdgelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Invest

Recommend

House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat

WASHINGTON (AP) — What was once a bipartisan effort to expand by 66 the number of federal district j

NFL power rankings Week 7: Where do Jets land after loss to Bills, Davante Adams trade?

NFL power rankings entering Week 7 of the 2024 season (previous rank in parentheses):1. Kansas City

Utah mother who raised over $1 million for her funeral dies from cancer

A Utah mom who started a GoFundMe page for own funeral has died after a two year battle with termina